Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
about
Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionDynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature ReviewAntiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxisEstimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural UgandaThe Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit AnalysisUniversal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda.Elements of Condom-Use Decision Making among South African Men Who Have Sex with MenEstimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community.The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV preventionTranslating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.Evaluating HIV prevention strategies for populations in key affected groups: the example of Cabo VerdeModeling and Cost-Effectiveness in HIV Prevention.Cost-Effectiveness and Quality of Care of a Comprehensive ART Program in Malawi.Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention.Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the Elimination Targets.Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study.Evaluating the impact of pulse oximetry on childhood pneumonia mortality in resource-poor settings.Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.PrEP Implementation Science: State-of-the-Art and Research Agenda.Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.Can we afford to offer pre-exposure prophylaxis to MSM in Catalonia? Cost-effectiveness analysis and budget impact assessment.The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.Choice of time horizon critical in estimating costs and effects of changes to HIV programmes.The Price of Prevention: Cost Effectiveness of Biomedical HIV Prevention Strategies in South AfricaCost-effectiveness of once-daily versus twice-daily regimens in the treatment of HIV infection in sub-Saharan Africa: a probabilistic decision model
P2860
Q27001897-287F9C32-A66D-453B-B53E-3554A9BF3625Q28072167-2950BD9B-BB88-4A9F-A5FE-A96E2EC56155Q28085433-4F99A48C-0166-4480-9DF5-C18F4A4394DEQ28551309-13174EF1-F882-415C-A1F3-3FC43017F895Q28608172-8DBA9ADF-D947-4D0F-8DF4-347AA1961742Q33634785-F1C881F2-7851-4CD1-B57E-C3118C38B0E1Q34214499-949B3227-DECF-43B7-81EE-AA8541B43D5DQ35668867-187DB79C-0E62-4EE3-9761-34B0F4C6383DQ35875723-AB44E8D5-5497-4E8F-928F-0F2B70946537Q35875746-9059CD6F-B963-40AB-BFB1-219CBBA95624Q35985240-ECE0CC6B-8E06-4578-B128-47CE709E9152Q36654828-891D6A3B-031C-498F-9197-DDA0037FE48FQ36992861-3C312B5B-27D8-4ABA-BB3E-62098B1C3D14Q37298218-E35F98D7-4AFD-469E-A7D2-B8FC36066042Q37305607-897F787F-FD24-4D89-B8F0-DDF9A2A5A232Q38452179-B7C46036-2A52-44B7-B9F6-7F5626326150Q38659668-B55CDC3E-2CCA-4872-906F-991FFBE3BA04Q39006821-2B65D317-A2ED-4337-B178-CDBDB8E1B6D6Q40668946-D447A897-8919-4502-AAFE-E26141930D18Q43241737-2BD2D443-97DF-49ED-BD72-0BB830EC8F88Q47549891-4732C0D2-0C0A-4E6A-9870-D28DFED872F4Q48375195-61566A07-8C4B-4A7F-9ADD-BC6992F9C7DEQ52656286-A05C8AC9-156A-4B4B-BD54-4D1E5C0C1177Q55088517-60F63E42-F73E-4398-9D56-BEEEC3DD3321Q56910975-E7252533-57A3-412F-BD66-0C460A5B1FC5Q57990836-A6EE4135-8193-4DF8-923E-93174F6FCC2A
P2860
Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparative effectiveness and ...... HIV prevention in South Africa
@ast
Comparative effectiveness and ...... HIV prevention in South Africa
@en
type
label
Comparative effectiveness and ...... HIV prevention in South Africa
@ast
Comparative effectiveness and ...... HIV prevention in South Africa
@en
prefLabel
Comparative effectiveness and ...... HIV prevention in South Africa
@ast
Comparative effectiveness and ...... HIV prevention in South Africa
@en
P2093
P2860
P921
P356
P1433
P1476
Comparative effectiveness and ...... HIV prevention in South Africa
@en
P2093
Eran Bendavid
Philip M Grant
Sabina S Alistar
P2860
P2888
P356
10.1186/1741-7015-12-46
P407
P577
2014-03-17T00:00:00Z
P5875
P6179
1008491276